nodes	percent_of_prediction	percent_of_DWPC	metapath
Decamethonium—ACHE—prostate cancer	0.79	1	CbGaD
Decamethonium—CHRNG—prostate gland—prostate cancer	0.00894	0.14	CbGeAlD
Decamethonium—CHRNE—testis—prostate cancer	0.00788	0.123	CbGeAlD
Decamethonium—CHRNG—seminal vesicle—prostate cancer	0.00756	0.118	CbGeAlD
Decamethonium—CHRNA1—prostate gland—prostate cancer	0.00592	0.0927	CbGeAlD
Decamethonium—CHRNA2—prostate gland—prostate cancer	0.00491	0.0769	CbGeAlD
Decamethonium—CHRNG—bone marrow—prostate cancer	0.00461	0.0722	CbGeAlD
Decamethonium—CHRNB1—prostate gland—prostate cancer	0.00457	0.0716	CbGeAlD
Decamethonium—ACHE—prostate gland—prostate cancer	0.00396	0.0621	CbGeAlD
Decamethonium—CHRM2—prostate gland—prostate cancer	0.00293	0.0459	CbGeAlD
Decamethonium—CHRNB1—testis—prostate cancer	0.00201	0.0315	CbGeAlD
Decamethonium—BCHE—prostate gland—prostate cancer	0.00195	0.0305	CbGeAlD
Decamethonium—ACHE—testis—prostate cancer	0.00175	0.0273	CbGeAlD
Decamethonium—BCHE—seminal vesicle—prostate cancer	0.00165	0.0258	CbGeAlD
Decamethonium—CHRNB1—lymph node—prostate cancer	0.00146	0.0229	CbGeAlD
Decamethonium—ACHE—lymph node—prostate cancer	0.00126	0.0198	CbGeAlD
Decamethonium—BCHE—bone marrow—prostate cancer	0.001	0.0157	CbGeAlD
Decamethonium—BCHE—testis—prostate cancer	0.000858	0.0134	CbGeAlD
Decamethonium—BCHE—lymph node—prostate cancer	0.000622	0.00974	CbGeAlD
Decamethonium—BCHE—Metabolism—PRKACB—prostate cancer	2.29e-05	0.000156	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP17A1—prostate cancer	2.27e-05	0.000155	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYP2E1—prostate cancer	2.26e-05	0.000154	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—IL6—prostate cancer	2.26e-05	0.000154	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—IGF1—prostate cancer	2.26e-05	0.000154	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.24e-05	0.000152	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—NQO1—prostate cancer	2.23e-05	0.000152	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CALCA—prostate cancer	2.22e-05	0.000151	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—APC—prostate cancer	2.22e-05	0.000151	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CG—prostate cancer	2.22e-05	0.000151	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GHR—prostate cancer	2.21e-05	0.00015	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—TH—prostate cancer	2.2e-05	0.00015	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—EGF—prostate cancer	2.19e-05	0.00015	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IRS1—prostate cancer	2.19e-05	0.00015	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.18e-05	0.000149	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—MMP2—prostate cancer	2.18e-05	0.000149	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PRKCQ—prostate cancer	2.18e-05	0.000149	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYP3A4—prostate cancer	2.18e-05	0.000148	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CXCL12—prostate cancer	2.17e-05	0.000148	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.16e-05	0.000148	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NCOA2—prostate cancer	2.16e-05	0.000147	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYP1B1—prostate cancer	2.14e-05	0.000146	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GSK3B—prostate cancer	2.13e-05	0.000145	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NRP1—prostate cancer	2.12e-05	0.000144	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—INS—prostate cancer	2.1e-05	0.000143	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—INS—prostate cancer	2.08e-05	0.000142	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GGT1—prostate cancer	2.07e-05	0.000141	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—SLC5A5—prostate cancer	2.06e-05	0.000141	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CREBBP—prostate cancer	2.06e-05	0.00014	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—ADRB2—prostate cancer	2.05e-05	0.00014	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—NCOA1—prostate cancer	2.04e-05	0.000139	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IGF1—prostate cancer	2.03e-05	0.000139	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—EGFR—prostate cancer	2.02e-05	0.000138	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP2E1—prostate cancer	2.01e-05	0.000137	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—IGF1—prostate cancer	2.01e-05	0.000137	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYP19A1—prostate cancer	2.01e-05	0.000137	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—VAV3—prostate cancer	2e-05	0.000136	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NQO1—prostate cancer	1.99e-05	0.000136	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PRKCQ—prostate cancer	1.98e-05	0.000135	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GNRH1—prostate cancer	1.97e-05	0.000134	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—VIP—prostate cancer	1.97e-05	0.000134	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MAP2K1—prostate cancer	1.96e-05	0.000134	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—TH—prostate cancer	1.96e-05	0.000134	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CD—prostate cancer	1.95e-05	0.000133	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.95e-05	0.000133	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—MMP2—prostate cancer	1.95e-05	0.000133	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP3A4—prostate cancer	1.94e-05	0.000132	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—RXRA—prostate cancer	1.94e-05	0.000132	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—ITPR1—prostate cancer	1.94e-05	0.000132	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—PIK3CA—prostate cancer	1.93e-05	0.000132	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.93e-05	0.000132	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—SERPINE1—prostate cancer	1.93e-05	0.000132	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—KRAS—prostate cancer	1.91e-05	0.00013	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP1B1—prostate cancer	1.91e-05	0.00013	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GRP—prostate cancer	1.9e-05	0.00013	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—LPAR1—prostate cancer	1.9e-05	0.00013	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.89e-05	0.000129	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—LRP2—prostate cancer	1.89e-05	0.000129	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PLCB2—prostate cancer	1.89e-05	0.000129	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—COMT—prostate cancer	1.87e-05	0.000128	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—FGF2—prostate cancer	1.87e-05	0.000127	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—ADRB2—prostate cancer	1.86e-05	0.000127	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GSTP1—prostate cancer	1.86e-05	0.000127	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—P4HB—prostate cancer	1.85e-05	0.000126	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CX3CL1—prostate cancer	1.85e-05	0.000126	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GGT1—prostate cancer	1.85e-05	0.000126	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—NOS3—prostate cancer	1.84e-05	0.000126	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ITPR1—prostate cancer	1.83e-05	0.000125	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NCOA1—prostate cancer	1.82e-05	0.000124	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—VAV3—prostate cancer	1.82e-05	0.000124	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HIST1H2BG—prostate cancer	1.81e-05	0.000124	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—CXCL8—prostate cancer	1.81e-05	0.000124	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.8e-05	0.000123	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GRB7—prostate cancer	1.8e-05	0.000123	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PDE4D—prostate cancer	1.8e-05	0.000123	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP19A1—prostate cancer	1.79e-05	0.000122	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—JAK2—prostate cancer	1.79e-05	0.000122	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—ITPR1—prostate cancer	1.76e-05	0.00012	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PIK3CA—prostate cancer	1.75e-05	0.00012	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HIST1H4H—prostate cancer	1.75e-05	0.00012	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CXCL8—prostate cancer	1.75e-05	0.000119	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MDM2—prostate cancer	1.75e-05	0.000119	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—RXRA—prostate cancer	1.73e-05	0.000118	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—TYMS—prostate cancer	1.73e-05	0.000118	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ERBB2—prostate cancer	1.72e-05	0.000117	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GNG5—prostate cancer	1.71e-05	0.000117	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GSTM1—prostate cancer	1.71e-05	0.000117	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CB—prostate cancer	1.7e-05	0.000116	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.68e-05	0.000115	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—LPL—prostate cancer	1.68e-05	0.000114	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—CTNNB1—prostate cancer	1.67e-05	0.000114	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—COMT—prostate cancer	1.67e-05	0.000114	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GSTP1—prostate cancer	1.66e-05	0.000113	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CXCL8—prostate cancer	1.63e-05	0.000111	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ITPR1—prostate cancer	1.63e-05	0.000111	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYP1A1—prostate cancer	1.62e-05	0.000111	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—CXCL8—prostate cancer	1.62e-05	0.00011	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ERCC2—prostate cancer	1.61e-05	0.00011	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.61e-05	0.00011	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CDKN1B—prostate cancer	1.6e-05	0.000109	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—AKT1—prostate cancer	1.58e-05	0.000108	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CASP3—prostate cancer	1.56e-05	0.000107	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL2—prostate cancer	1.56e-05	0.000106	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—IL6—prostate cancer	1.55e-05	0.000106	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—TYMS—prostate cancer	1.54e-05	0.000105	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GSTM1—prostate cancer	1.53e-05	0.000104	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CCND1—prostate cancer	1.52e-05	0.000104	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—MTHFR—prostate cancer	1.51e-05	0.000103	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CTNNB1—prostate cancer	1.51e-05	0.000103	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—LPL—prostate cancer	1.5e-05	0.000102	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—CTNNB1—prostate cancer	1.49e-05	0.000102	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTHLH—prostate cancer	1.49e-05	0.000102	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TGFBR1—prostate cancer	1.49e-05	0.000102	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PPARA—prostate cancer	1.48e-05	0.000101	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MMP9—prostate cancer	1.48e-05	0.000101	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CDKN1A—prostate cancer	1.47e-05	0.0001	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PTEN—prostate cancer	1.47e-05	0.0001	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AKR1C3—prostate cancer	1.47e-05	0.0001	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PRKACB—prostate cancer	1.46e-05	9.95e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP1A1—prostate cancer	1.45e-05	9.86e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ERCC2—prostate cancer	1.43e-05	9.78e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—AKT1—prostate cancer	1.43e-05	9.78e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—THBS1—prostate cancer	1.42e-05	9.7e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PPP3CA—prostate cancer	1.42e-05	9.7e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ANXA1—prostate cancer	1.4e-05	9.56e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—EP300—prostate cancer	1.4e-05	9.56e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CAV1—prostate cancer	1.39e-05	9.51e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PRKCZ—prostate cancer	1.38e-05	9.38e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—SRC—prostate cancer	1.36e-05	9.29e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—MTHFR—prostate cancer	1.35e-05	9.19e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CG—prostate cancer	1.34e-05	9.17e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.33e-05	9.08e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PARP1—prostate cancer	1.33e-05	9.06e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGFR4—prostate cancer	1.33e-05	9.06e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—VEGFA—prostate cancer	1.33e-05	9.05e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PPARA—prostate cancer	1.32e-05	9.02e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—STAT3—prostate cancer	1.31e-05	8.96e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CALCA—prostate cancer	1.31e-05	8.95e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCL12—prostate cancer	1.28e-05	8.74e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CG—prostate cancer	1.27e-05	8.66e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CAV1—prostate cancer	1.24e-05	8.48e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CG—prostate cancer	1.22e-05	8.33e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MYC—prostate cancer	1.22e-05	8.33e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TGFB1—prostate cancer	1.22e-05	8.31e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CASP9—prostate cancer	1.21e-05	8.23e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—INS—prostate cancer	1.2e-05	8.2e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—EGFR—prostate cancer	1.19e-05	8.14e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.19e-05	8.1e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CD—prostate cancer	1.18e-05	8.06e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CREBBP—prostate cancer	1.18e-05	8.03e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PRKCQ—prostate cancer	1.17e-05	7.98e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NGFR—prostate cancer	1.17e-05	7.98e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAP3K7—prostate cancer	1.16e-05	7.88e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CG—prostate cancer	1.13e-05	7.73e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—KRAS—prostate cancer	1.13e-05	7.69e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CD—prostate cancer	1.12e-05	7.61e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGF10—prostate cancer	1.11e-05	7.58e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ADRB2—prostate cancer	1.1e-05	7.5e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—JAK2—prostate cancer	1.08e-05	7.4e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—MAP2K1—prostate cancer	1.08e-05	7.37e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CD—prostate cancer	1.07e-05	7.32e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—VAV3—prostate cancer	1.07e-05	7.31e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—INS—prostate cancer	1.07e-05	7.31e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	1.06e-05	7.21e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—NOS3—prostate cancer	1.05e-05	7.19e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CREBBP—prostate cancer	1.05e-05	7.16e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ITPR1—prostate cancer	1.04e-05	7.09e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CA—prostate cancer	1.04e-05	7.07e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	1.03e-05	7.03e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TP53—prostate cancer	1e-05	6.84e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CD—prostate cancer	9.96e-06	6.79e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IGF1R—prostate cancer	9.94e-06	6.78e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	9.9e-06	6.75e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—JAK2—prostate cancer	9.85e-06	6.72e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CB—prostate cancer	9.73e-06	6.64e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PTGS2—prostate cancer	9.64e-06	6.57e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—LPL—prostate cancer	9.53e-06	6.5e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—IL2—prostate cancer	9.46e-06	6.45e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	9.45e-06	6.44e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NOS3—prostate cancer	9.4e-06	6.41e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	9.36e-06	6.38e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ITGB3—prostate cancer	9.21e-06	6.28e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL6—prostate cancer	9.18e-06	6.26e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	8.99e-06	6.13e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ERBB3—prostate cancer	8.93e-06	6.09e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGFR2—prostate cancer	8.92e-06	6.08e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CB—prostate cancer	8.68e-06	5.92e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PTGS2—prostate cancer	8.6e-06	5.87e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL2—prostate cancer	8.59e-06	5.86e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TERT—prostate cancer	8.56e-06	5.84e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—AKT1—prostate cancer	8.47e-06	5.77e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PTEN—prostate cancer	8.41e-06	5.73e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HIF1A—prostate cancer	8.19e-06	5.58e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—EP300—prostate cancer	8.02e-06	5.47e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—LEP—prostate cancer	7.99e-06	5.45e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CAV1—prostate cancer	7.92e-06	5.4e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—KDR—prostate cancer	7.83e-06	5.34e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ESR1—prostate cancer	7.63e-06	5.2e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PTEN—prostate cancer	7.5e-06	5.12e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—BAD—prostate cancer	7.45e-06	5.08e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—APC—prostate cancer	7.21e-06	4.92e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	7.21e-06	4.92e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—EP300—prostate cancer	7.15e-06	4.88e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EGF—prostate cancer	7.13e-06	4.86e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IRS1—prostate cancer	7.13e-06	4.86e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GSK3B—prostate cancer	6.92e-06	4.72e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—INS—prostate cancer	6.83e-06	4.66e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CREBBP—prostate cancer	6.69e-06	4.56e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IGF1—prostate cancer	6.6e-06	4.5e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—EGFR—prostate cancer	6.57e-06	4.48e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	6.38e-06	4.35e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	6.34e-06	4.32e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	6.28e-06	4.28e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	6.27e-06	4.28e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—KRAS—prostate cancer	6.21e-06	4.23e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGF2—prostate cancer	6.07e-06	4.14e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NOS3—prostate cancer	5.99e-06	4.08e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CA—prostate cancer	5.93e-06	4.04e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—JAK2—prostate cancer	5.82e-06	3.97e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	5.7e-06	3.89e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MDM2—prostate cancer	5.68e-06	3.87e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ERBB2—prostate cancer	5.6e-06	3.82e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	5.53e-06	3.77e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCL8—prostate cancer	5.31e-06	3.62e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CA—prostate cancer	5.29e-06	3.61e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	5.19e-06	3.54e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	5.13e-06	3.5e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CASP3—prostate cancer	5.08e-06	3.47e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL2—prostate cancer	5.08e-06	3.46e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL6—prostate cancer	5.05e-06	3.44e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCND1—prostate cancer	4.95e-06	3.37e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	4.9e-06	3.34e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—AKT1—prostate cancer	4.84e-06	3.3e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MMP9—prostate cancer	4.8e-06	3.28e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	4.79e-06	3.26e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTEN—prostate cancer	4.78e-06	3.26e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—AKT1—prostate cancer	4.66e-06	3.18e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EP300—prostate cancer	4.55e-06	3.11e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SRC—prostate cancer	4.43e-06	3.02e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—AKT1—prostate cancer	4.32e-06	2.95e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—VEGFA—prostate cancer	4.31e-06	2.94e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—STAT3—prostate cancer	4.27e-06	2.91e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MYC—prostate cancer	3.97e-06	2.71e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TGFB1—prostate cancer	3.96e-06	2.7e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EGFR—prostate cancer	3.88e-06	2.65e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—KRAS—prostate cancer	3.67e-06	2.5e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	3.37e-06	2.3e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TP53—prostate cancer	3.26e-06	2.22e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL6—prostate cancer	2.98e-06	2.03e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AKT1—prostate cancer	2.75e-06	1.88e-05	CbGpPWpGaD
